Richard F. W.
Jackson
*a,
Ian
Rilatt
a and
P. John
Murray
b
aDepartment of Chemistry, Dainton Building, University of Sheffield, Brook Hill, Sheffield, UK S3 7HF. E-mail: r.f.w.jackson@shef.ac.uk
bOSI Pharmaceuticals, Watlington Road, Oxford, UK OX4 6LT
First published on 18th November 2003
Palladium-catalysed reaction of unprotected 2-, 3-, and 4-iodophenols with a range of amino acid derived organozinc reagents (not used in excess) gives the expected products in good to excellent yield, demonstrating that carbon–zinc bonds are not protonated by acidic phenols under the conditions of palladium-catalysed coupling reactions.
It has been known for some time that carbon–zinc bonds can tolerate the presence of acidic protons, for example in the organozinc reagents 2–5.3–5 Knochel et al. have shown that organozinc halides can be formed in the presence of a range of additives containing acidic protons, although the presence of these additives does reduce the yield of the organozinc reagent.6 Most interestingly, it was demonstrated that reactions that proceed rapidly at low temperature, for example reaction of organocopper reagents with allylic electrophiles, can be carried out in the presence of additives containing free hydroxyl groups, including phenol (although the yield of product was slighly reduced).6 These results imply that, under the right circumstances, protection of free hydroxyl groups may not be required. Since this is important for the application of organozinc chemistry to the chemical modification of peptides, which may incorporate a range of acidic protons, we have decided to test it experimentally.
Our recent discovery that it is possible to prepare the methyl ester analogue of the trifluoroacetyl-protected organozinc reagent 1a,7 in which the pKa of the NH proton is estimated to be around 17 (in DMSO),8 prompted us to consider whether other protons of comparable acidity might also be tolerated in the electrophile, and the most obvious and useful functional group that fulfils this criterion appeared to be phenol (the pKa of phenol measured in DMSO is 18).8 We have therefore explored the cross-coupling of free iodophenols with a range of functionalised zinc reagents, since this would give direct access to tyrosine analogues, without the need for hydroxyl protection.†
![]() | ||
| Scheme 1 Reagents and conditions: 4-IC6H4OH, DMF, Pd2(dba)3 (2.5 mol%), P(o-tol)3 (10 mol%), r.t. | ||
Having established this principle, we have explored the coupling of a range of other amino acid-derived organozinc reagents with unprotected 2-, 3- and 4-iodophenol, which allowed us to isolate the free phenols 7–11, and our results are given in Table 1. The very high yields obtained in the cross coupling with 3- and 4-iodophenol using zinc reagent 1b are a striking demonstration of the tolerance exhibited by this reagent towards acidic protons. The lower yield obtained with 2-iodophenol reflects the behaviour of other 2-substituted iodobenzene derivatives in similar coupling reactions.4 Finally, attempted reaction of 3b with 3,4-dihydroxyiodobenzene unfortunately gave none of the desired product, L-DOPA, indicating the enhanced acidity of catechol is sufficient to ensure competitive protonation of the zinc reagent.
| Organozinc | Electrophile | Product | Ar | Yield (%)a |
|---|---|---|---|---|
| a Isolated yields refer to homogeneous material purified by flash chromatography. | ||||
| 1a | 4-IC6H4OH | 6 | 4-HOC6H4 | 66 |
| 1b | 2-IC6H4OH | 7a | 2-HOC6H4 | 42 |
| 1b | 3-IC6H4OH | 7b | 3-HOC6H4 | 88 |
| 1b | 4-IC6H4OH | 7c | 4-HOC6H4 | 85 |
| 2 | 4-IC6H4OH | 8 | 4-HOC6H4 | 64 |
| 3b | 4-IC6H4OH | 9a | 4-HOC6H4 | 59 |
| 3b | 3-IC6H4OH | 9b | 3-HOC6H4 | 54 |
| 4 | 4-IC6H4OH | 10 | 4-HOC6H4 | 48 |
| 5 | 4-IC6H4OH | 11 | 4-HOC6H4 | 49 |
In a single experiment, we have also established that an unprotected benzylic alcohol functionality can be tolerated; the cross-coupling reaction of zinc reagent 1b with 3-iodobenzyl alcohol gave the product 12 (Scheme 2), although the yield was modest (42%).
![]() | ||
| Scheme 2 Reagents and conditions: 3-IC6H4CH2OH, DMF, Pd2(dba)3 (2.5 mol%), P(o-tol)3 (10 mol%), r.t. | ||
O); 1708 (C
O); 1180 (C–O). Found C, 48.85; H, 3.70; N, 4.32. C13H12NO5F3 requires C, 48.91; H, 3.79; N, 4.39%. δH
(250 MHz, CDCl3) 2.98 (1H, dd, J 17.5 and 4.0), 3.22 (1H, dd, J 17.5 and 4.5), 4.82–4.98 (1H, m), 5.27 (2 H, s), 7.28–7.41 (5H, m) and 7.45 (1H, d, J 8.5); δC
(62.5 MHz, CDCl3) 35.3, 48.7, 67.6, 115.5 (q, J 283), 128.4, 128.7, 129.7, 134.7, 157.3 (q, J 34), 170.8 and 173.9; m/z
(EI) 319.0668 (8%, M+, C13H12NO5F3 requires 319.0667), 184(6), 166(3), 140(5), 108(100), 107(56) and 99(10); [α]22.5D
+59.1 (c 1.02 in CHCl3).
O); 1710 (C
O); 1209 (C–O). Found C, 49.19; H, 3.53; N, 6.69. C17H15O7N2F3 requires C, 49.05; H, 3.63; N, 6.73%. δH
(250 MHz, CDCl3) 2.85 (4H, s), 3.02 (1H, dd, J 17.5 and 4.5), 3.27 (1H, dd, J 17.5 and 4.5), 5.11–5.28 (2H, m), 5.28–5.38 (1H, m), 7.36 (5H, s) and 7.72 (1H, d, J 8.5); δC
(62.5 MHz, CDCl3) 25.5, 35.5, 47.4, 67.7, 115. 5 (q, J 285), 128.6, 128.7, 129.6, 134.8, 157.0 (q, J 39), 165.3, 168.5 and 169.7; m/z
(EI) 416.0835 (12%, M+, C17H15O7N2F3 requires 416.0835), 273(4), 224(6), 184(24), 166(4), 139(18), 115(11), 108(25) and 107(43); [α]22.5D
+ 7.0 (c 1.01 in CHCl3).
O). Found C, 51.25; H, 4.66; N, 4.60. C13H14O4NF3 requires C, 51.15; H, 4.62; N, 4.59%. δH
(250 MHz, CDCl3) 2.22 (1H, br t), 2.77 (2H, d, J 6), 3.69–3.87 (2H, m), 4.28–4.43 (1H, m), 5.15 (2H, s) and 7.36 (5H, s); δC
(62.5 MHz, CDCl3) 34.8, 48.7, 62.9, 67.1, 115.8 (q, J 287), 128.4, 128.6, 128.7, 135.1, 157.4 (q, J 38), and 171.3. m/z
(EI) 306.0955 (1 %, MH+, C13H15O4NF3 requires 306.0953), 305(3), 198(7), 139(24), 108(91), 107(43), 91(100) and 79(44); [α]22.5D
+ 9.1 (c 0.99 in CHCl3).
O); 1702 (C
O); 1186 (C–O). Found C, 37.88; H, 3.06; N, 3.21; I, 30.57. C13H13O3NF3I requires C, 37.61; H, 3.16; N, 3.37; I, 30.57%. δH
(250 MHz, CDCl3) 2.75 (1H, dd, J 17.0 and 5.5), 2.95 (1H, dd, J 17.0 and 5.0), 3.30–3.50 (2H, m), 4.23–4.40 (1H, m), 5.17 (2H, s), 7.14 (1H, d, J 17.0) and 7.30–7.50 (5H, m); δC
(62.5 MHz, CDCl3) 7.1, 37.7, 47.7, 67.2, 115.7 (q, J 288), 128.4, 128.6, 128.7, 135.1, 156.8 (q, J 37), and 170.2; m/z
(EI) 414.9906 (13%, M+, C13H13O3NF3I requires 414.9892), 308(5), 266(7), 195(9), 154(3), 139(7), 108(100) and 107(32); [α]22.5D
+ 7.0 (c 1.00 in CHCl3).
O); 1516 (N–H). Found C, 59.36; H, 4.67; N, 3.52. C19H18F3NO4 requires C, 59.84; H, 4.76; N, 3.67. δH
(400 MHz, CD3OD) 2.58 (1H, dd, J 15.5 and 8.5), 2.64 (1H, dd, J 15.5 and 5.5), 2.69 (1H, dd, J 13.5 and 8), 2.75 (1H, dd, J 14 and 6.5), 4.39–4.49 (1H, m), 5.04 (1H, d, J 12), 5.09 (1H, d, J 12), 6.69 (2H, d, J 8.5) and 6.96 (2H, d, J 8.5). δC
(100 MHz, CD3OD) 39.0, 40.0, 50.5, 67.6, 116.2, 117.4 (q, J 287), 129.2, 129.3, 129.4, 129.5, 131.3, 137.3, 157.3, 158.3 (q, J 37) and 172.1; m/z
(TOF MS ES+) 382.1262 (7%, MH+, C19H19F3NO4 requires 382.1266), 304(10) and 251(100).
O); 1534 (N–H). Found C, 68.69; H, 6.96; N, 3.49. C22H27NO5 requires C, 68.55; H, 7.06; N, 3.63%. δH
(250 MHz, CDCl3) 1.44 (9H, s), 2.59 (2H, br d, J 5), 2.60 (1H, m (signal partially obscured)), 3.01–3.12 (1H, m), 3.83–4.01 (1H, m), 5.16 (2H, s), 5.53 (1H, br d, J 7.5), 6.79 (1H, t, J 7.5), 6.88 (1H, d, J 7.6), 6.96 (1H, d, J 7.5), 7.13 (1H, t, J 7.5), 7.37 (5H, s) and 7.85 (1H, br s). δC
(62.5 MHz, CDCl3) 28.2, 36.1, 36.7, 48.5, 66.6, 80.4, 116.3, 119.8, 123.2, 128.3, 128.4, 128.6, 130.8, 135.4, 155.4, 156.4, and 171.7 (one signal obscured); m/z
(EI+) 385.1875 (3%, M+, C22H27NO5 requires 385.1889), 385(3), 222(19), 178(64) and 91(100); [α]22.1D
+19.6 (c 1.02 in CHCl3).
O); 1691 (C
O); 1513 (N–H). Found C, 68.48; H, 7.02; N, 3.51. C22H27NO5 requires C, 68.55; H, 7.06; N, 3.63%. δH
(250 MHz, CDCl3) 1.40 (9H, s), 2.49 (1H, dd, J 16.5 and 6), 2.56 (1H, dd, J 16.5 and 6), 2.73 (1H, dd, J 13 and 7.9), 2.85 (1H, dd, J 13.5 and 6.5), 4.07–4.26 (1H, m), 5.09 (1H, d, J 12), 5.10 (1H, signal partially obscured), 5.17 (1H, d, J 12), 5.85 (1H, s), 6.58–6.78 (3H, m), 7.11 (1H, t, J 8) and 7.36 (5H, s). δC
(62.5 MHz, CDCl3) 28.3, 37.6, 40.2, 48.7, 66.5, 79.7, 113.7, 116.2, 121.2, 128.3, 128.5, 129.5, 135.5, 139.0, 155.4, 156.3 and 171.6 (one signal obscured); m/z
(EI+) 385.1888 (5%, M+, C22H27NO5 requires 385.1889), 278(62), 222(62) and 178(100); [α]22.1D
+6.9 (c 1.02 in CHCl3).
O); 1686 (C
O); 1529 (N–H). Found C, 68.32; H, 6.96; N, 3.41. C22H27NO5 requires C, 68.55; H, 7.06; N, 3.63%. δH
(400 MHz, (CD3)2CO) 1.40 (9H, s), 2.58 (2H, d, J 6.5), 2.75 (1H, dd, J 13.5 and 7), 2.83 (1H, dd, J 13.5 and 7), 4.07–4.23 (1H, m), 5.06–5.20 (2H, m), 5.95 (1H, br d, J 7.5), 6.79 (2H, d, J 8), 7.07 (2H, d, J 8), 7.27–7.54 (5H, m) and 8.19 (1H, s). δC
(100 MHz, (CD3)2CO) 28.7, 39.4, 40.4, 50.7, 66.7, 78.9, 116.0, 128.9, 129.0, 129.4, 130.0, 131.3, 137.5, 156.0, 156.9 and 171.9; m/z
(EI+) 385.1887 (3%, M+, C22H27NO5 requires 385.1889), 268(56), 222(42), 178(82) and 91(100); [α]22.1D
+6.9 (c 1.02 in CHCl3).
O); 1683 (C
O); 1516 (N–H). Found C, 63.08; H, 8.13; N, 4.22. C17H25NO5 requires C, 63.14; H, 7.79; N, 4.33%. δH
(400 MHz, CD3OD) 1.36 (9H, s), 1.50–1.64 (1H, m), 1.76–1.88 (1H, m), 2.29 (1H, dd, J 16.5 and 7), 2.36 (1H, dd, J 16.5 and 6.5), 3.62 (4H, s (two overlapping signals)), 6.68 (2H, d, J 8.5) and 7.00 (2H, d, J 8.5). δC
(100 MHz, CD3OD) 28.8, 30.6, 31.7, 41.8, 52.1, 53.1, 79.8, 116.0, 130.7, 131.3, 156.8, 158.1 and 175.6; m/z
(EI+) 323.1731 (3%, M+, C17H25NO5 requires 323.1733), 216(32), 160(17), 116(72) and 107(59); [α]22.5D
+1.0 (c 1.02 in MeOH).
O); 1720 (C
O); 1690 (C
O). Found C, 60.88; H, 7.82; N, 4.42. C15H21NO5 requires C, 61.00; H, 7.17; N, 4.74%; m/z
(EI+) 295.1409 (4%, M+, C22H27NO5 requires 295.1420), 239(25), 178(100), 136(22) and 107(24); [α]22.5D
+38.6 (c 1.04 in CHCl3), literature value [α]25D
+34.2 (c 1.18 in CHCl3).13
O); 1716 (C
O); 1689 (C
O); 1516 (N–H). Found C, 68.14; H, 7.45; N, 3.51. C22H27NO5 requires C, 68.55; H, 7.06; N, 3.63%. δH
(400 MHz, CDCl3) 1.45 (9H, s), 1.80–1.95 (1H, m), 2.00–2.14 (1H, m), 2.43–2.60 (2H, m), 4.32–4.43 (1H, m), 5.09 (1H, d, J 12.5), 5.18 (1H, d, J 12.5), 5.18 (1H, signal partially obscured), 6.21 (1H, s), 6.72 (2H, d, J 8.5), 6.91 (2H, d, J 8.5) and 7.33 (5H, s). δC
(100 MHz, CDCl3) 28.3, 30.5, 34.4, 53.2, 67.1, 80.3, 115.3, 128.3, 128.4, 128.6, 129.4, 132.2, 135.2, 154.3, 155.5 and 172.6; m/z
(EI+) 385.1880 (6%, M+, C22H27NO5 requires 385.1889), 329(31), 238(24), 209(15), 177(100) and 107(35); [α]22.5D
−18.5 (c 1.08 in MeOH).
O); 1716 (C
O); 1688 (C
O); 1516 (N–H). Found C, 68.72; H, 7.60; N, 3.42. C23H29NO5 requires C, 69.15; H, 7.32; N, 3.51%. δH
(400 MHz, CDCl3) 1.48 (9H, s), 1.54–1.73 (3H, m), 1.79–1.93 (1H, m), 2.45–2.60 (2H, m), 4.37–4.35 (1H, m), 5.12 (1H, d, J 12.5), 5.20 (1H, signal partially obscured), 5.23 (1H, d, J 12.5), 6.20 (1H, s), 6.77 (2H, d, J 8.5), 6.95 (2H, d, J 8.5) and 7.32–7.43 (5H, m). δC
(100 MHz, CDCl3) 27.6, 28.7, 32.5, 34.7, 53.8, 67.5, 80.7, 115.6, 128.7, 128.9, 129.0, 129.8, 133.7, 135.7, 154.6, 156.0 and 173.3; m/z
(EI+) 399.2055 (1%, M+, C23H29NO5 requires 399.2046), 320(29), 305(100), 208(13), 165(13) and 91(23); [α]22.5D
−21.3 (c 1.04 in MeOH).
O); 1685 (C
O); 1530 (N–H). δH
(400 MHz, CDCl3) 1.38 (9H, s), 2.25 (1H, br s), 2.46 (1H, dd, J 16 and 6), 2.54 (1H, dd, J 16 and 6), 2.77 (1H, dd, J 13.5 and 8), 2.90 (1H, dd, J 13.5 and 6.5), 4.09–4.21 (1H, m), 4.60 (2H, s), 5.08 (1H, d, J 12.5), 5.09 (1H, signal partially obscured), 5.14 (1H, d, J 13.5) and 7.01–7.46 (9H, m). δC
(100 MHz, CDCl3) 28.3, 37.6, 40.2, 48.8, 65.0, 66.4, 79.4, 125.2, 127.9, 128.3, 128.5, 128.6, 132.0, 132.9, 135.6, 137.9, 141.2, 155.1 and 171.5; m/z
(EI+) 422.1935 (8%, MNa+, C23H29NO5Na requires 422.1943), 400(9), 344(29), 321(100), 300(33) and 282(28); [α]22.5D
+9.7 (c 1.04 in MeOH).
Footnote |
| † There is a report14 concerning the coupling of zinc reagent 3a with unprotected 2-iodo-3-hydroxypyridine15 which gave the expected product in 33% yield, but the reaction used 2 equivalents of the organozinc reagent, so the possibility that the free hydroxyl group might have been tolerated in the reaction was not addressed. In another report, which highlights the desirability of avoiding the use of protecting groups, 2-chloro-3-hydroxy-6-iodopyridine was protected as its TBS-ether prior to Pd-catalysed coupling with the zinc reagent 3a, and the protecting group was removed immediately afterwards.16 |
| This journal is © The Royal Society of Chemistry 2004 |